SCHEMBL21552702

SCHEMBL21552702

BrCCc1ccc(Br)cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 2/20 0.44
GRM2 Q14416 1/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ADRA2A P08913 2/20 0.35
ADRA2B P18089 2/20 0.35
ADRA2C P18825 2/20 0.35
PLAU P00749 1/20 0.35
GLS O94925 1/20 0.35
MBOAT4 Q96T53 1/20 0.34
TSHR P16473 1/20 0.33
RAB9A P51151 2/20 0.32
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2A Q12879 1/20 0.32
GRIN2B Q13224 1/20 0.32
GRIN2C Q14957 1/20 0.32
GRIN3A Q8TCU5 1/20 0.32
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20802798 0.84 GBA1 (0.42) GBA1GRM2ALDH1A1KDM4EADRA2A
SCHEMBL507025 0.81
SCHEMBL3231706 0.80 GBA1 (0.52) GBA1GRM2ALDH1A1KDM4EADRA2A
SCHEMBL165821 0.80 HRH1 (0.47) GBA1GRM2ALDH1A1KDM4EADRA2A
SCHEMBL5650 0.80 GBA1 (0.42) GBA1GRM2ALDH1A1KDM4EADRA2A
SCHEMBL31729646 0.80 GBA1 (0.52) GBA1GRM2ALDH1A1KDM4EADRA2A
SCHEMBL7433897 0.80 GBA1 (0.42) GBA1GRM2ALDH1A1KDM4EADRA2A
SCHEMBL5674 0.80 GBA1 (0.42) GBA1GRM2ALDH1A1KDM4EADRA2A
Hydrochloric Acid SCHEMBL14157238 0.78 HRH1 (0.45) GBA1GRM2ALDH1A1KDM4EADRA2A
Hydrochloric Acid SCHEMBL2713143 0.78 HRH1 (0.45) GBA1GRM2ALDH1A1KDM4EADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019217977-A1 N-ACYLETHANOLAMINE HYDROLYZING ACID AMIDASE (NAAA) INHIBITORS AND USE THEREOF NORTHEASTERN UNIVERSITY (US) 2019-11-14 WO disclosed
CN-102666541-B Purine or deazapurine derivatives for the treatment of, in particular, viral infections GILEAD SCIENCES, INC. (US) 2015-11-25 CN disclosed
CN-103965167-A Imidazole carboxylic acid derivative TONGHUA JIDA PHARMACEUTICAL CO LTD 2014-08-06 CN disclosed
CN-103596951-A 8-ethyl-6-(aryl)pyrido [2,3-d]pyrimidin-7(8h)-ones for the treatment of nervous system disorders and cancer AFRAXIS INC 2014-02-19 CN disclosed
CN-102666541-A Purine or deazapurine derivatives for the treatment of, in particular, viral infections GILEAD SCIENCES INC 2012-09-12 CN disclosed
CN-102329267-A 6-substituted 2,3,4, 5-tetrahydro-1H-benzo [d] aza as 5-HT2Creceptor agonists LILLY CO ELI 2012-01-25 CN disclosed
CN-102311387-A 6-substituted 2,3,4, 5-tetrahydro-1H-benzo [d] aza as 5-HT2Creceptor agonists LILLY CO ELI 2012-01-11 CN disclosed
CN-101128461-B Imidazo (1, 2-a) pyridine compounds as VEGF-R2 inhibitors LILLY CO ELI 2010-12-22 CN disclosed
CN-101506195-A Novel pyridone derivatives having MCH antagonistic activity and medicaments comprising these compounds BOEHRINGER INGELHEIM INT (DE) 2009-08-12 CN disclosed
CN-101495502-A N-terminally modified GLP-1 receptor modulators BRISTOL MYERS SQUIBB CO (US) 2009-07-29 CN disclosed
CN-100439340-C 3-cyanoquinolines, 3-cyano-1, 6-naphthyridines, and 3-cyano-1, 7-naphthyridines as protein kinase inhibitors WYETH CORP (US) 2008-12-03 CN disclosed
CN-101128461-A Imidazo (1, 2-a) pyridine compounds as VEGF-R2 inhibitors LILLY CO ELI (US) 2008-02-20 CN disclosed
CN-1993335-A Indanone potentiators of metabotropic glutamate receptors MERCK & CO INC (US) 2007-07-04 CN disclosed
CN-1934088-A As 5-HT2c6-substituted 2,3,4, 5-tetrahydro-1H-benzo [ d ] receptor agonists]Aza * LILLY CO ELI (US) 2007-03-21 CN disclosed
CN-1419545-A 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors WYETH CORP (US) 2003-05-21 CN disclosed